Sanofi-Aventis has completed the acquisitions of a 50 percent stake in animal health firm Merial from joint venture partner Merck & Co Inc for $4.0 billion in a deal that will be earnings enhancing from the first year.

Merial will report to Hanspeter Spek, Sanofi said on Friday.

(Reporting by Marcel Michelson)